Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 52 for “"AURKA"”.
-
Aurka inhibition-based combination therapy approaches in glioblastoma.
Glioblastoma is the most common and aggressive central nervous system tumor in adults with a 6% survival rate. Decades of research for improving life expectancy and quality of life have been ineffective. The discovery of better treatment strategies is urgent to improve the survival rates for …
-
Investigating The Interaction of Aurka and Ube2C In Colorectal Cancer Cells
… its highest co-expression with Aurora kinase A (AURKA) pathway members, i.e. with AURKA and its binding co-factor and activator TPX2, all being localized on chromosome 20q. In addition, preliminary immunoblotting experiments in a panel of ten CRC cell lines showed high positive correlation …
-
Disease modeling on tumor organoids implicates AURKA as a therapeutic target in liver metastatic colorectal cancer
… 20q13.2, which contains the Aurora kinase A (AURKA) locus, and displayed elevated mRNA and protein levels of AURKA compared to normal colonic epithelium. Treatment with the AURKA inhibitor Alisertib, which also represents a strategy to target MYC indirectly in different cancer types, restored …
-
Implications of NEDD9 on AURKA activity: a biomarker for sensitization and therapeutic target in solid tumors
… through activation of mitotic Aurora A kinase (AURKA), and invasion, through regulation of Src kinase and matrix metalloproteinase 14, MMP14, activity. The overall aim of my work is to determine the role of NEDD9 in tumorigenesis and its implications on AURKA activity in tumor cells. AURKA is up …
-
Exploring the Roles of Insulin Resistance and AURKA in Esophageal Adenocarcinoma: Early Detection and Prognostic Significance
… is linked to the promotion of mitosis, with AURKA acting as a pivotal regulator of the cell cycle during mitosis. Inhibiting AURKA expression has been shown to improve IR conditions. However, the carcinogenic effects of AURKA and its relationship with the TME in EAC remain inadequately …
-
Modification of RHAMM and TPX2 optimizes Aurora kinase A (AURKA) inhibition in malignant peripheral nerve sheath tumours
… molecular brake for the mitotic kinase Aurora A (AURKA), so this loss of HMMR in high-grade MPNST may cause tumours to rely on AURKA activity and sensitizes them to aurora kinase inhibitors (AKI). Three MPNST cell-lines were profiled for the expression and activity of AURKA, as well as their …
-
Nuclear AURKA-driven early dissemination of breast cancer uncovers opposing roles of HIF-1A and HIF-1B in metastasis
… demonstrated that the nuclear Aurora kinase A (N-AURKA) protein activates HIF1 under oxygenated conditions (oxHIF1) and induces dissemination from early-stage tumors (eDTCs). These eDTCs can be found in multiple distant organs and produce highly proliferative metastases in preclinical models. …
-
Nuclear Aurora-A kinase-induced hypoxia signaling drives dissemination and metastasis in breast cancer.
… Here we reveal that presence of Aurora-A Kinase (AURKA) in the nucleus and metastatic dissemination are molecularly connected through HIF1 (Hypoxia induced factor-1) signaling. The nuclear AURKA in the complex with constitutively expressed HIF-1β subunit activates transcription of “hypoxia induced …
-
Disrupting inhibitory-kappaB kinase (IKK)-Aurora kinase signalling in prostate cancer cells
… of cancer-related death in men. Aurora kinase A (AURKA) is commonly overexpressed in PCa and when active is bound to its activating cofactor, Targeting protein for Xklp2 (TPX2), preventing the dephosphorylation and degradation of AURKA. AURKA interacts with the I?B kinase (IKK) proteins, IKK?, …
-
Protein expression and interaction of the kinases Src and Aurora A in esophageal carcinoma
… in Western countries.<br>The kinases SRC and AURKA are both involved in processes and signaling pathways that are crucial for normal cellular behavior. Several studies indicate an association of SRC and AURKA dysregulation and the development of ESCC and EAC. Nevertheless, the kinases’ …
-
Aurora kinase A enables collective invasion by endowing a leader cell phenotype and stabilizing EPLIN-mediated cohesion with follower cells
… of cells, termed leader cells, Aurora kinase A (AURKA) has been found to be highly expressed, and its expression is elevated in multiple cancers, including breast cancer. Although it is known that AURKA may play a role in collective migration and some functions have been elucidated, its specific …
-
Aurora kinase A, regulated by HMMR and TPX2, controls cell migration and engraftment via centrosome polarization
… interconnect them. HYPOTHESIS- Aurora kinase A (AURKA) – hyaluronan mediated motility receptor (HMMR) – targeting protein for XKlp2 (TPX2), which control microtubule nucleation during mitosis, enable cancer cell engraftment and migration via microtubule organization at polarized centrosomes. …
-
PPP1R2 COORDINATES KINASE AND PHOSPHATASE ACTIVITY TO REGULATE THE CENTROSOME AND MIDBODY
… 1, PP1, and an activator of Aurora A Kinase, AURKA. Both PP1 and AURKA play critical roles in centrosome regulation, however PPP1R2's role at the centrosome has not been examined. Given that PPP1R2 interacts with PP1 and AURKA, critical regulators of the centrosome, I hypothesized that PPP1R2 …
-
Transkriptions-/Replikationskonflikte als therapeutisches Ziel von \(MYC\)-gesteuerten kolorektalen Karzinomen
… neben weiteren Bindungspartnern Aurora Kinase A (AURKA) an das Chromatin. Eine Hemmung von AURKA führt zu einer Störung der RNA-Prozessierung und einer Aktivierung des ATR-Signalwegs. Dies trägt zu einer erneuten Stabilisierung der Replikationsgabeln und zur Limitierung der R-Loop-Bildung bei. …
-
Role Of Aurora Kinase A, Rab4a, And Endolysosomes In The Development Of Alzheimer’s Disease-Like Pathology
… focused on the role played by aurora kinase A (AURKA) and Rab4a proteins in the development of AD-like pathology. Alzheimer’s disease is the leading cause of dementia worldwide in people older than 65 years of age. There is currently no cure for AD and mechanisms underlying the pathogenesis of …
-
SMARCA4/BRG1-Inactivating Mutations as Potential Predictive Markers for Aurora Kinase A-Targeted Therapy in NSCLCs
… screening, we show here that Aurora kinase A (AURKA) activity is essential in NSCLCs carrying SMARCA4/BRG1-inactivating mutations. RNAi-mediated depletion or chemical inhibition of AURKA induces apoptosis and diminish cellular viability in SMARCA4/BRG1-mutant NSCLC cells in vitro and in mouse …
-
Aurora Kinase B inhibition in non-small cell lung and head and neck cancer
… invariable metastatic disease. Aurora Kinase A (AURKA) and Aurora Kinase B (AURKB) are both overexpressed in these cancers and are linked with poor survival rates. We have hypothesised that increased AURKA and AURKB expression is linked with radioresistance in NSCLC and HNSCC; inhibitors of both …
-
Finding Synergistic Lipid Kinase and Mitotic Kinase Inhibitor Combination Treatments for Metastatic Breast Cancer
… lethal interaction with Aurora kinase A (AURKA) gene. Here, I investigated if PI3K and AURKA inhibitors will act synergistically to eliminate TNBC cell growth and motility in culture models and halt progression in mouse tumor models. Testing dose responses of buparlisib and/or alisertib …
-
Dissecting chromatin and cytoskeletal regulatory functions of SETD2 in ccRCC
… are known to be targeted by Aurora A Kinase (AURKA), we showed that cilia formation in ccRCC cells is reduced after treatment with the AURKA kinase inhibitor Alisertib, implying that AURKA may have an effect on SETD2’s catalytic function. We also showed that EPZ-719, a novel SETD2 inhibitor, …
Page 1 of 3